Heart Team Approach to Complex Tricuspid Valve Disease

Moderator(s)

• 

  Brian Bethea, MD

  Chief of Cardiac Surgery MedStar Union Memorial Hospital
  MedStar
  Phoenix, Maryland, United States

  Disclosure(s): Abbott Laboratories: Consultant (Ongoing), Speaker (Ongoing); Edwards Life Science: Consultant (Ongoing)
• 

  Howard Song, MD, PhD (he/him/his)

  Professor and Chief, Division of Cardiothoracic Surgery
  Oregon Health & Science University
  Portland, Oregon, United States

  Disclosure(s): Edwards: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Presentations:

• 11:30 AM – 11:35 AM PT

  Case Presentation
  

  Kimberly A. Holst, MD (she/her/hers) – Mayo Clinic
• 11:35 AM – 11:42 AM PT

  Optimal Medical Treatment of Functional TR: Guideline-Driven Approach
  

  Dipti Itchhaporia, MD, MACC, FAHA, FESC, FRCP – American College of Cardiology
• 11:42 AM – 11:49 AM PT

  Surgical Tricuspid Repair/Replacement: Rationale and Technique
  

  Yasir Abu-Omar, MD PhD FRCS – University Hospitals Cleveland Medical Center
• 11:49 AM – 11:56 AM PT

  Impact of Surgical Strategy on Outcomes of Isolated Tricuspid Valve Surgery: An Analysis of the STS Adult Cardiac Surgery Database
  

  Qiudong (Kevin) Chen, MD (he/him/his) – Cedars Sinai Medical Center
• 11:56 AM – 12:03 PM PT

  Discussant for The Richard E. Clark Paper for Adult Cardiac Surgery
  

  James Gammie, MD – Johns Hopkins University
• 12:03 PM – 12:10 PM PT

  Transcatheter Tricuspid Repair/Replacement: Rationale and Technique
  

  Matthew J. Price, MD – Scripps Clinic
• 12:10 PM – 12:30 PM PT

  Heart Team Discussion